ARCHIVES

FDA Ponders Standards For “Retrospective Prospective” Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996

NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent.

February 23, 2001

In Brief: Cooper Says HEW May Stop Taking New Construction grants; Cancer Act Does Not Give Him That Right

May 2, 1975

About Face; NCI To Keep Preclinical AIDS Drug Development

December 12, 1986